Department of Endocrinology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Syst Rev. 2021 Jan 7;10(1):12. doi: 10.1186/s13643-020-01566-5.
Existing self-management and behavioural interventions for diabetes vary widely in their content, and their sustained long-term effectiveness is uncertain. Autonomy supporting interventions may be a prerequisite to achieve 'real life' patient engagement and more long-term improvement through shared decision-making and collaborative goal setting. Autonomy supportive interventions aim to promote that the person with diabetes' motivation is autonomous meaning that the person strives for goals they themselves truly believe in and value. This is the goal of self-determination theory and guided self-determination interventions. Self-determination theory has been reviewed but without assessing both benefits and harms and accounting for the risk of random errors using trial sequential analysis. The guided self-determination has not yet been systematically reviewed. The aim of this protocol is to investigate the benefits and harms of self-determination theory-based interventions versus usual care in adults with diabetes.
METHODS/DESIGN: We will conduct the systematic review following The Cochrane Collaboration guidelines. This protocol is reported according to the PRISMA checklist. A comprehensive search will be undertaken in the CENTRAL, MEDLINE, EMBASE, LILACS, PsycINFO, SCI-EXPANDED, CINAHL, SSCI, CPCI-S and CPCI-SSH to identify relevant trials. We will include randomised clinical trials assessing interventions theoretically based on guided self-determination or self-determination theory provided face-to-face or digitally by any healthcare professional in any setting. The primary outcomes will be quality of life, mortality, and serious adverse events. The secondary will be diabetes distress, depressive symptoms and adverse events not considered serious. Exploratory outcomes will be glycated haemoglobin and motivation. Outcomes will be assessed at the end of the intervention and at maximum follow-up. The analyses will be performed using Stata version 16 and trial sequential analysis. Two authors will independently screen, extract data from and perform risk of bias assessment of included studies using the Cochrane risk of bias tool. Certainty of the evidence will be assessed by GRADE.
Self-determination theory interventions aim to promote a more autonomous patient engagement and are commonly used. It is therefore needed to evaluate the benefit and harms according to existing trials.
PROSPERO CRD42020181144.
现有的糖尿病自我管理和行为干预在内容上差异很大,其长期持续效果也不确定。支持自主的干预措施可能是实现“现实生活”患者参与和通过共同决策和协作目标设定实现更长期改善的前提。自主支持干预旨在促进糖尿病患者的动机是自主的,这意味着患者追求自己真正相信和重视的目标。这是自我决定理论和指导性自我决定干预的目标。自我决定理论已经得到了审查,但没有评估收益和危害,并使用试验序贯分析来考虑随机错误的风险。指导性自我决定干预尚未得到系统审查。本方案的目的是研究基于自我决定理论的干预措施与常规护理在糖尿病成人中的收益和危害。
方法/设计:我们将按照 Cochrane 协作组的指南进行系统评价。本方案按照 PRISMA 清单进行报告。将在 CENTRAL、MEDLINE、EMBASE、LILACS、PsycINFO、SCI-EXPANDED、CINAHL、SSCI、CPCI-S 和 CPCI-SSH 中进行全面搜索,以确定相关试验。我们将纳入理论上基于指导性自我决定或自我决定理论的随机临床试验,这些试验由任何医疗保健专业人员在任何环境中面对面或通过数字方式提供。主要结局将是生活质量、死亡率和严重不良事件。次要结局将是糖尿病困扰、抑郁症状和不被视为严重的不良事件。探索性结局将是糖化血红蛋白和动机。结局将在干预结束时和最大随访时进行评估。分析将使用 Stata 版本 16 和试验序贯分析进行。两位作者将独立筛选、提取数据并使用 Cochrane 偏倚风险工具对纳入研究进行风险偏倚评估。证据的确定性将通过 GRADE 进行评估。
自我决定理论干预旨在促进更自主的患者参与,因此根据现有试验评估其收益和危害是必要的。
PROSPERO CRD42020181144。